Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Enrollment open in phase II trial of OTL-38 imaging agent for ovarian cancer

Jan. 14, 2015

Biocept and Insight Genetics to advance NSCLC diagnostics

Jan. 13, 2015

Advanced Accelerator Applications acquires Atreus and starts phase I/II trial of imaging agent

Jan. 9, 2015

FDA approves Gadavist as contrast agent for pediatric patients under age 2

Jan. 7, 2015

Innovate Biopharmaceuticals to acquire RG-1068 assets

Jan. 7, 2015

European approval for Xpert HIV-1 Viral Load test

Dec. 30, 2014

ADDC and AstraZeneca to support five high-throughput screening proposals

Dec. 30, 2014

Amarantus BioScience's Alzheimer's disease diagnostic available for use in clinical trials

Dec. 30, 2014

Abbott completes acquisition of medical device company

Dec. 29, 2014

Scientists at M2i Development disclose novel diagnostic agents

Dec. 16, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...